amlodipine has been researched along with celecoxib in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (6.67) | 29.6817 |
| 2010's | 7 (46.67) | 24.3611 |
| 2020's | 7 (46.67) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Honda, K; Izumi, T; Miyaji, Y; Nakayama, S; Okazaki, O; Okudaira, N; Shiosakai, K; Sugiyama, D; Suzuki, W; Takakusa, H; Watanabe, A | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Meyer-Wyss, B; Rich, P; Zinsser, P | 1 |
| Cooper-DeHoff, RM; Smith, SM | 1 |
| Angeli, F; Reboldi, G; Signorotti, S; Trapasso, M; Verdecchia, P | 1 |
| Jhaj, R; Shukla, AK | 1 |
| Abdel Hamid, MA; Mabrouk, MM; Michael, MA | 1 |
| Abd El-Hay, SS; Attala, K; Eissa, MS; El-Henawee, MM; Hasan, MA | 1 |
| Attala, K; Elsonbaty, A | 1 |
| Ahmed, SS; Majumder, M; Maneesh, MU; Pasha, TY; Ramesh, B | 1 |
| Piszczatoski, CR; Smith, SM | 1 |
| Amin, NH; El-Saadi, MT; Mohamed, NR; Sharkawi, MMZ | 1 |
3 review(s) available for amlodipine and celecoxib
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Fixed-Dose Combination Amlodipine/Celecoxib (Consensi) for Hypertension and Osteoarthritis.
Topics: Amlodipine; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Celecoxib; Humans; Hypertension; Osteoarthritis | 2019 |
Amlodipine and celecoxib for treatment of hypertension and osteoarthritis pain.
Topics: Amlodipine; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Celecoxib; Drug Combinations; Humans; Hypertension; Osteoarthritis; Pain | 2018 |
12 other study(ies) available for amlodipine and celecoxib
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Combination of GSH trapping and time-dependent inhibition assays as a predictive method of drugs generating highly reactive metabolites.
Topics: Glutathione; Pharmacology; Sulfur Radioisotopes | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Hepatotoxicity induced by celecoxib and amlodipine.
Topics: Aged; Aged, 80 and over; Amlodipine; Antihypertensive Agents; Celecoxib; Cholestasis, Intrahepatic; Cyclooxygenase Inhibitors; Female; Humans; Middle Aged; Pyrazoles; Sulfonamides | 2004 |
Consensi: Is it a conscientious combination?
Topics: Amlodipine; Antihypertensive Agents; Arthralgia; Blood Pressure; Celecoxib; Clinical Trials as Topic; Cyclooxygenase 2 Inhibitors; Drug Approval; Drug Combinations; Humans; Hypertension; Medication Adherence; Osteoarthritis; Patient Safety; Research Design; United States; United States Food and Drug Administration | 2019 |
A fast and green reversed-phase HPLC method with fluorescence detection for simultaneous determination of amlodipine and celecoxib in their newly approved fixed-dose combination tablets.
Topics: Amlodipine; Celecoxib; Chromatography, High Pressure Liquid; Fluorescence; Molecular Structure; Spectrometry, Fluorescence; Tablets | 2020 |
An enhanced first derivative synchronous spectrofluorimetric method for determination of the newly co-formulated drugs, amlodipine and celecoxib in pharmaceutical preparation and human plasma.
Topics: Amlodipine; Celecoxib; Humans; Pharmaceutical Preparations; Plasma; Spectrometry, Fluorescence | 2020 |
Consensi --a fixed dose combination of amlodipine and celecoxib.
Topics: Amlodipine; Antihypertensive Agents; Calcium Channel Blockers; Celecoxib; Cyclooxygenase 2 Inhibitors; Drug Combinations; Humans; Hypertension; Osteoarthritis | 2020 |
Smart UV spectrophotometric methods based on simple mathematical filtration for the simultaneous determination of celecoxib and ramipril in their pharmaceutical mixtures with amlodipine: A comparative statistical study.
Topics: Amlodipine; Celecoxib; Pharmaceutical Preparations; Ramipril; Spectrophotometry | 2021 |
A Simple Bioanalytical Method for Simultaneous Estimation of Amlodipine and Celecoxib in Rat Plasma by High Performance Liquid Chromatography.
Topics: Amlodipine; Animals; Celecoxib; Chromatography, High Pressure Liquid; Female; Linear Models; Male; Rats; Rats, Wistar; Reproducibility of Results; Sensitivity and Specificity | 2021 |
Fixed-dose combination amlodipine-celecoxib for treatment of hypertension and osteoarthritis pain: an up-to-date evaluation.
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Celecoxib; Drug Combinations; Humans; Hypertension; Osteoarthritis; Pain | 2021 |
Five spectrophotometric methods for simultaneous determination of Amlodipine besylate and celecoxib in presence of its toxic impurity.
Topics: Amlodipine; Celecoxib; Spectrophotometry | 2021 |